Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$15.14 – $28.00
22% from low
Exchange
OTC Link
ADRC
Borrow rate
4.39%
Moderate
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $27.47B | $26.72B | $23.14B | $26.83B | $29.19B | $27.01B | $26.41B | $15.72B |
| Cost of revenue | $15.92B | $15.44B | $13.45B | $15.30B | $17.57B | $15.51B | $14.73B | $9.06B |
| Gross profit | $11.55B | $11.28B | $9.69B | $11.54B | $11.61B | $11.50B | $11.68B | $6.66B |
| Gross margin | 42.0% | 42.2% | 41.9% | 43.0% | 39.8% | 42.6% | 44.2% | 42.3% |
| R&D | $98.0M | $83.0M | $171.0M | $237.0M | $229.0M | $224.0M | $0 | $149.9M |
| Operating income | $3.31B | $3.83B | $3.37B | $4.40B | $3.22B | $4.58B | $4.64B | $2.23B |
| EBITDA | $5.42B | $6.51B | $4.84B | $6.42B | $5.34B | $6.82B | $6.83B | $3.51B |
| Net income | $1.50B | $2.25B | $1.70B | $2.30B | $3.31B | $3.06B | $2.93B | $804.1M |
| Net margin | 5.5% | 8.4% | 7.3% | 8.6% | 11.3% | 11.3% | 11.1% | 5.1% |
| EPS (diluted) | 0.50 | 0.74 | 0.55 | 0.74 | 1.09 | 1.07 | 1.04 | 0.29 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $16.7B | $0.74 | $0.73–$0.77 | 2 |
| 2027 | $18.3B | $0.85 | $0.84–$0.88 | 2 |
| 2028 | $19.2B | $0.97 | $0.90–$1.00 | 1 |
| 2029 | $20.8B | $1.06 | $0.99–$1.10 | 1 |
Forward consensus · source: Financial Modeling Prep
HOLCIM LTD UNSP/ADR
No one on the platform currently holds HCMLY.
No tracked institution reports a position in HCMLY as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-05-19 | $0.3603 | 2026-06-05 |
| 2025-07-28 | $10.6303 | 2025-07-25 |
| 2025-05-27 | $0.6981 | 2025-06-06 |
| Execution date | Ratio |
|---|---|
| 2015-09-10 | 21-for-20 |
No one on the platform has traded HCMLY yet.
| -1.90% |
| $40.6B |
| — |
| FSUMFFortescue Ltd | $14.00 | +3.70% | $43.1B | — |
| GLCNFGlencore plc | $6.82 | +0.55% | $79.7B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 8.7× earnings vs its 13.6× historical median P/E.
Fair value ≈ $28.20 · price $18.00 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.